Observational studyDeutsches Arzteblatt international2026
Heart Disease in Survivors of Childhood Cancer: Data From the German Childhood Cancer Registry and Statutory Health Insurance Carriers (the VersKiK Study).
Observational study in Deutsches Arzteblatt international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac and cardiovascular diseases are major causes of morbidity in the growing population of childhood cancer survivors, particularly as a result of treatment with anthracyclines and radiotherapy to the chest.
methodsThe VersKiK study is based on record linkage between the German Childhood Cancer Registry and 13 statutory health insurance carriers (69% coverage of the German statutorily insured population). Registry data with information on primary cancers in childhood or adolescence were linked to data from the participating health insurance carriers. Cardiac diseases were analyzed in 11 863 patients with cancer diagnosed between 1991 and 2011 who survived at least 5 years after their diagnosis (up to January 2017). The health insurance data covered the years 2017-2021. The childhood cancer survivors were matched to a comparison group of 35 589 insurees without childhood cancer by age, sex, region of residence within Germany, and duration of insurance.
resultsCardiac diseases were identified in 6.4% of the 5-year survivors of childhood cancer and in 2.5% of the matched comparison group. Cardiomyopathy, valvular disease, and arrhythmia were the most common heart diseases in the survivors (1.9%, 2.7%, 1.5%). The largest difference from the comparison group was observed for cardiomyopathy (prevalence ratio = 14.0; 95% confidence interval: [10.9; 20.5]).
conclusionLong-term survivors of childhood cancer in Germany are more likely to be diagnosed with cardiac disease than the general population of the same age. Systematic medical monitoring and individualized preventive measures for survivors are indicated. In the interpretation of these findings, it should be noted that the childhood cancer survivors underwent more intensive long-term medical follow-up than their counterparts in the comparison group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.